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Objective: To determine the prevalence and factors associated with nonmedical use of 
prescription medication (NMUPM) among adolescents who use drugs (ages 12 to 17 years) 
in Quebec.
Method: Secondary data analyses were carried out with data from a 6-month study, 
namely, the 2010–2011 Quebec Health Survey of High School Students—a large-
scale survey that sought to gain a better understanding of the health and well-being of 
young Quebecers in high school. Bivariate and multivariate logistic regression analyses 
were conducted to study NMUPM among adolescents who use drugs, according to 
sociodemographic characteristics, peer characteristics, health indicators (anxiety, 
depression, or attention-deficit disorder [ADD] with or without hyperactivity), self-
competency, family environment, and substance use (alcohol and drug use) factors.
Results: Among adolescents who had used drugs in the previous 12 months, 5.4% (95% 
CI 4.9% to 6.0%) reported NMUPM. Based on multivariate analyses, having an ADD 
(adjusted odds ratio [AOR] 1.47; 95% CI 1.13 to 1.91), anxiety disorder (AOR 2.14; 95% CI 
1.57 to 2.92), low self-esteem (AOR 1.62; 95% CI 1.26 to 2.08), low self-control (AOR 1.95; 
95% CI 1.55 to 2.45), low parental supervision (AOR 1.43; 95% CI 1.11 to 1.83), regular 
alcohol use (AOR 1.72; 95% CI 1.36 to 2.16), and polysubstance use (AOR 4.09; 95% CI 
3.06 to 5.48) were associated with increased odds of reporting NMUPM.
Conclusions: The observed prevalence of NMUPM was lower than expected. However, 
the associations noted with certain mental health disorders and regular or heavy use of 
other psychoactive substances are troubling. Clinical implications are discussed.
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Utilisation non médicale des médicaments d’ordonnance chez les 
adolescents utilisant des drogues au Québec 
Objectif : Déterminer la prévalence de l’utilisation non médicale des médicaments 
d’ordonnance (UNMMO) et les facteurs qui y sont associés chez les adolescents (de 12 à 
17 ans) qui utilisent des drogues au Québec.
Méthode : Des analyses de données secondaires ont été exécutées avec les données 
d’une étude de 6 mois, l’Enquête québécoise sur la santé des jeunes du secondaire 2010-
2011, une enquête de grande envergure visant à obtenir une meilleure compréhension 
de la santé et du bien-être des jeunes québécois du secondaire. Des analyses de 
régression logistique bivariée et multivariée ont été menées pour étudier l’UNMMO 
chez les adolescents qui utilisent des drogues, selon les facteurs des caractéristiques 
sociodémographiques, des caractéristiques des pairs, des indicateurs de la santé (anxiété, 
dépression, ou trouble de déficit de l’attention [TDA] avec ou sans hyperactivité), de l’auto-
efficacité, de l’environnement familial, et de l’utilisation de substances (utilisation d’alcool et 
de drogues). 
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Abbreviations
ADD     attention-deficit disorder
ADHD    attention-deficit hyperactivity disorder
ISQ     Institut de la statistique du Québec
NMUPM    nonmedical use of prescription medication
QHSHSS  Quebec Health Survey of High School Students
Clinical Implications
• NMUPM is associated with mental health problems in 
adolescents, problems that are either underdiagnosed 
or suboptimally treated.
• Increased efforts in the detection of young people with 
NMUPM are needed, especially among those who use 
illicit drugs.
Limitations
• Our study design was cross-sectional and, therefore, 
temporal relations could not be examined.
• Difficulty in accurately assessing NMPUM may have 
caused an underestimation of the problem.
• Although there is a potential impact of desirability bias, 
it is less likely, as the subsample already reported 
having used drugs in the past.
Nonmedical use of prescription medications is now a serious health problem in North America.1 There has 
been a substantial increase in the misuse of prescribed 
opioids, psychoactives, and stimulants in the United 
States and Canada during the past few decades. The high 
availability and use of prescription medications have 
created environments conducive to NMUPM in North 
America.2–5 There are social and health harms associated 
with prescription medications, and although these drugs 
have therapeutic purposes, they are likely to be misused 
because of their psychoactive properties and associated 
risks for psychological and physical dependence. Excluding 
tobacco and alcohol, prescription medications are the 
most prevalent type of drug used in North America after 
cannabis.6
Use of NMUPM is more prevalent among adolescents and 
young adults than among older adults.7–9 According to data 
from the Youth Smoking Survey 2010–11, 8.2% of young 
Canadians in grades 6 to 12 reported taking prescription 
and over-the-counter medications in the past year for 
recreational purposes (to get high).10 Studies have shown 
that teenagers think prescription medications are much 
safer to use11 and easier to get than street drugs.12 In the 
United States, the Substance Abuse and Mental Health 
Service Administration estimated that annual drug-related 
visits to emergency departments involving misuse or abuse 
of prescription medications increased 115% between 2004 
and 2010.13 The 12- to 17-year-old age group accounted 
for 6.1% of visits, which is 300.6 visits to emergency 
departments per 100 000 people.14
It is important to prevent or reduce adolescents’ 
psychoactive substance use. During adolescence, the brain 
undergoes rapid and extensive development.15 lt is more 
vulnerable to the effects of alcohol and drug use that can 
lead to neurological and behavioural changes associated 
with higher risk of substance abuse and multiple drug 
use.16–21 Moreover, misuse of prescription medications 
comes with its share of consequences, including physical 
injuries, psychiatric conditions, problems with the law, 
fatal and nonfatal overdoses, respiratory depression, heart 
arrhythmia, and increased risks for HIV and hepatitis C 
virus infections.22–27
Several studies have examined factors that characterize 
adolescents who use prescription medications for 
nonmedical purposes. According to a systematic review 
covering scientific papers published between 2001 and 
2011,28 almost all studies reported a positive association 
between drug use and NMUPM, yet no studies to date have 
examined correlates of NMUPM among adolescents who 
use drugs. Using data from the QHSHSS 2010–2011, we 
carried out secondary analyses to estimate the prevalence 
of NMUPM and associated correlates among adolescents 
who reported using substances illicitly. Sociodemographic 
characteristics, peer characteristics, health indicators, and 
factors related to self-competency, family environment, and 
substance use were examined.
Résultats : Parmi les adolescents qui avaient utilisé des drogues dans les 12 mois 
précédents, 5,4 % (IC à 95 % 4,9 % à 6,0 %) déclaraient une UNMMO. Selon les analyses 
multivariées, un TDA (ratio de cotes ajusté [RCC] 1,47; IC à 95 % 1,13 à 1,91), un trouble 
anxieux (RCC 2,14; IC à 95 % 1,57 à 2,92), une faible estime de soi (RCC 1,62; IC à 95 % 
1,26 à 2,08), un faible autocontrôle (RCC 1,95; IC à 95 % 1,55 à 2,45), une faible supervision 
parentale (RCC 1,43; IC à 95 % 1,11 à 1,83), une utilisation d’alcool régulière (RCC 1,72;  
IC à 95 % 1,36 à 2,16), et une utilisation de polysubstances (RCC 4,09; IC à 95 % 3,06 à 
5,48) étaient associés à des probabilités accrues de déclarer une UNMMO.
Conclusions : La prévalence observée de l’UNMMO était plus faible que prévu. Cependant, 
les associations notées entre certains troubles de santé mentale et l’utilisation régulière ou 
intensive d’autres substances psychoactives sont inquiétantes. Les implications cliniques 
sont discutées.
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Methods
Study Design
This cross-sectional study was based on data collected in the 
QHSHSS 2010–2011, a survey based on a representative 
sample of high school students living in the province of 
Quebec. The survey was carried out by the ISQ, with the 
aim to assess physical, mental, and psychosocial health and 
lifestyle habits of high school students. Ethical approval 
was obtained from the ethical committee of the institute.
Description of the Quebec Health Survey of High 
School Students
Full methodological details on the QHSHSS have 
previously been described.29,30 Briefly, all pupils enrolled in 
high school grades 1 to 5 (12 to 17 years old) in public or 
private schools in the fall of 2010 were eligible, excluding 
those from the regions of Nunavik and Terres-Cries-de-la-
Baie-James, vocational and technical schools, schools in 
which the language of instruction is an Aboriginal language, 
institutions that are not in the education system (other 
ministries or the federal government), and schools where 
at least 30% of students are disabled or have adjustment 
difficulties or learning disabilities. Schools were selected 
for the QHSHSS as follows: for both given health region 
and grade level (for example, secondary 1), schools were 
selected randomly and in proportion to their size from 
among all schools with students enrolled in that particular 
grade level. Then, based on a standard social science 
course, a list of classes was made for each school selected 
for a given grade level. Classes were then selected from this 
list. Numerous classes in the same school may have been 
selected.
Data Collection
The survey was based on a computerized self-administered 
questionnaire, and took place between November 2, 2010, 
and May 17, 2011, in the 16 health regions involved. On 
the day of data collection in a given school, a team of 2 
interviewers brought the necessary equipment with them, 
including computers, routers, and a server. Before data 
collection began in a given class, youth were informed 
about the survey objectives and the collection procedures. 
They were also told that participation was voluntary. During 
collection, the interviewers were available to answer any 
questions from the youth. A total of 63 196 students in 
2651 secondary 1 to 5 classes at 470 schools completed the 
QHSHSS 2010–2011, for a final overall response rate of 
88.1%.
Measures
Students could choose to fill out the questionnaire in 
either French or English. The section on drug use started 
with a general question about lifetime drug use. Among 
adolescents who answered yes, drug use during the past 
12 months was assessed using DEP-ADO, a questionnaire 
validated for screening adolescents.31 It covered use of 
7 different types of illicit drugs and use of a medication 
taken without prescription, for an effect. A list of examples 
of medications was provided, including Valium, Librium, 
Dalmane, Halcion, Ativan, Ritalin, Dilaudid, codeine, 
and OxyContin. Adolescents who reported having used a 
medication were asked to name it. Each answer was verified 
by one of the authors, who is a physician, to make sure that 
the substance named was a true medication. This question 
made it possible to identify the youth reporting NMUPM 
(the outcome under study) among adolescents who had used 
any drugs or medications in the previous 12 months (the 
subsample under study). The number of categories of illicit 
substances used by participants during the 12-month period 
was estimated and treated as a dichotomous covariable (1, 
compared with 2 or more). Lifetime regular use of alcohol, 
defined as at least once a week during at least a month, was 
also measured.
As for the other covariates, several domains were examined. 
They were selected based on the literature and their interest 
as modifiable factors for the purpose of prevention. The 
mental health domain included 3 questions asking the 
youth if they had any of the following health problems 
that had been diagnosed or confirmed by a doctor or other 
health professionals: attention problems with or without 
hyperactivity, anxiety, and depression. The self-competency 
domain included 3 constructs, and for each one, participants 
were classified into 2 groups: low, compared with 
moderate, or high. One construct was self-esteem, assessed 
using the Rosenberg Index.32 The second was global self-
efficacy, measured with questions on self-confidence and 
perseverance previously used in similar surveys carried out 
in the United States and Canada.33,34 The third construct was 
self-control, which refers to a person’s ability to override 
impulses and interrupt or restrain an internal reaction to 
avoid undesired behaviours or to reach a goal or follow a 
rule.35 Some questions from Tangney et al’s35 index of self-
control were retained to examine this dimension, and a brief 
index was developed.
The family domain included 3 measures. One was an index 
of social support in the home environment, which included 7 
questions about students’ perceptions of the quality of their 
relationships with their parents or other adults in their home 
and about high expectations expressed by those adults.36 
The second measure was level of meaningful participation 
in the home; 3 questions focused on a student’s perception 
of his or her contributions to family life. Finally, 2 questions 
from the parenting style measurement instrument based on 
an instrument developed by Steinberg et al,37 were used to 
assess the third measure, level of parental supervision. In 
our analyses, participants were classified into 2 groups: low 
supervision, compared with medium, or high supervision.
Relationships with friends were assessed using 2 measures. 
One referred to the level of social support from friends. 
It is a scale that measures if students think they benefit 
from significant support from their friends.36,38 The second 
measure uses questions to determine the degree to which 
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a participant’s friends have prosocial behaviours.36,38 
Again, in our analyses, scores were treated as dichotomous 
covariables, with values corresponding to low, compared 
with medium, or high scores.
Statistical Analyses
The 17 565 QHSHSS participants who reported using 
drugs in the past year were included in the analyses. For 
each variable, weighted proportions were estimated and 
their 95% confidence intervals were calculated using 
the bootstrap confidence intervals method based on the 
empirical distribution of the estimates.39 Bivariate analyses 
were performed for each explanatory variable and NMUPM. 
Interactions between sex and mental health covariates were 
also examined. Then analyses were carried out for each 
specific domain, where variables within each domain were 
analyzed together. Second, significant variables within each 
domain subanalyses were then considered in a backward-
stepwise regression model, with a P value of 0.05 or less to 
stay in the model controlling for sex. SUDAAN software40 
was used to perform the analyses.
Results
Among the 17 565 participants who had used drugs, 847 
participants reported they had used a medication without a 
prescription for an effect, for a weighted proportion of 5.4% 
(95% CI 4.9% to 6.0%). There was no difference between 
boys 5.5% (95% CI 4.8% to 6.2%) and girls 5.3% (95% CI 
4.5% to 6.3%). The most popular class of medications was 
stimulants (2.7%), followed by opioids (1.9%), sedatives, 
hypnotics, and other tranquilizers (1.1%), and other drugs 
(0.1%) (for examples, antiinflammatory drugs).
Table 1 shows the distribution of all covariates, and 
comparisons between boys and girls. Almost one-third 
of the youth (31.9%) reported regular alcohol use in 
their lifetime and 45.8% of youth reported using more 
than 1 illicit drug in the previous 12 months. ADDs with 
or without hyperactivity were reported by 17.7% of the 
sample, while the presence of anxiety and depression was 
reported by 12.2% and 9.2%, respectively. One-quarter 
of participants had low global self-efficacy (25.5%) and a 
similar proportion had low self-esteem (22.7%). More than 
one-third of the sample had low self-control. Although one-
third of the sample reported low parental supervision, only 
a minority said they had low support from their families. 
Few youth found that they had low support from their 
friends or that their friends had low prosocial behaviours. 
Except for family support, there are substantial differences 
between boys and girls.
Results of bivariate analyses and domain-specific 
multivariate logistic regression models are presented in 
Table 2. The final multivariate model presented in Table 3 
shows that participants with some mental health problems, as 
well as some self-competency and parental characteristics, 
were more likely to report NMUPM. These include ADDs 
(AOR 1.47; 95% CI 1.13 to 1.91) and anxiety disorders 
(AOR 2.14; 95% CI 1.57 to 2.92), low self-esteem (AOR 
1.62; 95% CI 1.26 to 2.08) and low self-control (AOR 1.95; 
95% CI 1.55 to 2.45), and low parental supervision (AOR 
1.43; 95% CI 1.11 to 1.83). Regular alcohol use (AOR 1.72; 
95% CI 1.36 to 2.16) and polysubstance use (AOR 4.09; 
95% CI 3.06 to 5.48) also increased the odds of reporting 
NMUPM.
Discussion
In our study, we examined the prevalence and key correlates 
of NMUPM among Quebec adolescents who reported 
using drugs. The observed prevalence of NMUPM (5.4%) 
is lower than that reported in adolescents of the same 
age who, unlike our sample, had not all necessarily used 
drugs in the past year. In Canada, according to the Youth 
Smoking Survey 2010–11, 8.2% reported any NMUPM 
in the previous year.10 Further, in that study, opioids 
were the most often used prescription medication (14% 
of respondents, compared with 4.1% for stimulants and 
1.9% for tranquilizers). In our study, stimulants were the 
most popular, followed by opioids. Several factors could 
explain these differences. A first hypothesis is based on the 
results of a recent study41 on prescription opioid analgesics 
dispensing in Canada, which showed that dispensing 
patterns varied among provinces, particularly because of 
regulatory frameworks. This could explain, at least in part, 
the differences observed in prevalence of NMUPM and 
class of medications used. It is also possible that patterns of 
use of nonmedical prescription medications vary depending 
on whether youth use drugs (our study sample). Indeed, 
young drug users may be using drugs to achieve effects that 
may differ from those sought by the other youth: in the first 
case, use of prescription medication is often for a specific 
purpose, such as to relieve the negative effects of drugs or 
to boost the pleasant effects.
Sex differences observed among participants regarding 
the prevalence of several correlates is similar to what we 
know in the general adolescent literature. For instance, 
boys were more likely to have ADDs, while girls were more 
likely to have anxiety and depression.42,43 Controlling for 
sex, our results reveal that, in adolescents who have used 
drugs, NMUPM is associated with several factors that 
suggest personal and environmental vulnerability. Low 
self-esteem and low self-control were found to be positively 
associated with NMUPM. The links between NMUPM 
and these characteristics have not yet been thoroughly 
documented. However, the results are consistent with the 
theory that those characteristics are dispositional factors 
showing a propensity to engage in risk taking.44 As for 
family environment, our results are coherent with Ford,45 
who found that adolescents with strong bonds to parents 
were less likely to report NMUPM. In fact, similar to low 
self-esteem and low self-control, low parental supervision 
could foster risk taking, including the possibility of using 
medications stored in family medicine cabinets. Note that 
together, these factors separate young people who engage in 
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NMUPM from those who do not, even in a sample of youth 
who reported having used drugs.
Study participants who reported ADDs and anxiety 
disorders diagnosed or confirmed by a doctor or other 
health professional were more likely to endorse NMUPM. 
There is a dearth of literature on the relation between 
anxiety and NMUPM among adolescents. According to a 
Mississippi study46 of 6790 youth in grades 6 to 12 enrolled 
in public schools, young people with symptoms consistent 
with anxiety disorders were more likely to report lifetime 
NMUPM. While they were unable to verify this hypothesis, 
the authors suggest that these young people were engaging 
in NMUPM to self-medicate. As for hyperactivity, in 
Canada, self-medication seems to play an important role. 
According to a 2002 Student Drug Use Survey carried out 
in the Atlantic Provinces, 26% of the adolescents who had 
prescriptions for methylphenidate had given or sold some 
of their pills.47 Further, self-reported ADHD symptoms 
were found to be associated with the nonmedical use of 
methylphenidate and its diversion. We should underline 
that in our study, questions about mental health concerned 
diagnoses confirmed by professionals and not symptoms; 
therefore, respondents who reported problems were or 
had been in contact with the health system. In short, what 
emerges from the literature and our study results is that 
NMUPM is at least partly linked to mental health problems 
in adolescents, problems that are either underdiagnosed or 
suboptimally treated.
Our finding that regular alcohol and polysubstance use 
increase the odds of reporting NMUPM is not unexpected. In 
a recent systematic review, 3 US-wide representative studies 
(National Survey on Drug Use and Health, Monitoring 
the Future, and the National Survey of Adolescents—
Replication) and 6 non-nationally representative studies 
found positive associations between NMUPM and other 
illicit drug use.28 Our work adds to this body of evidence. 
It demonstrates that among adolescents who reported using 
at least one drug in the past year, NMUPM is associated 
with possibly problematic co-use of alcohol or several 
illicit drugs during the same period. However, those young 
people’s patterns of co-usage are not known. Studies are 
needed to examine where use of medications fits in the 
process of initiation to substance use and in substance use 
patterns involving combinations.
Our study results need to be considered in light of the 
following limitations. First, it is possible that some youth 
did not recognize the names of medications presented as 
examples or did not report the use of other medications 
than the examples proposed. This would underestimate 
the extent of NMUPM in the sample. The difficulty of 
accurately assessing NMUPM and even problems of 
inconsistency between studies in the wording of questions 
Table 1  Characteristics of participants having used psychoactive substances in the previous 12 months  
(n = 17 565) 
Total Male Female
Characteristics n (%)  95% CI n (%) 95% CI n (%) 95% CI P
Substance use
Lifetime regular alcohol use 5708 (31.9) 30.7 to 33.1 3285 (35.0) 33.4 to 36.6 2423 (28.5) 26.8 to 30.3 <0.001
Number of illicit drugs used 
(≥2)
7737 (45.8) 44.5 to 47.2 3723 (43.1) 41.5 to 45.0 4014 (48.7) 46.9 to 50.5 <0.001
Mental health
Attention-deficit disorder 
with or without hyperactivity 
2878 (17.7) 16.8 to 18.8 1760 (20.7) 19.4 to 22.1 1118 (14.5) 13.3 to 15.9 <0.001
Anxiety disorder 2045 (12.2) 11.5 to 12.9 714 (8.0) 7.2 to 8.9 1331 (16.7) 15.5 to 18.0 <0.001
Depression 1427 (9.2) 8.5 to 9.9 564 (7.3) 6.4 to 8.2 863 (11.3) 10.2 to 12.5 <0.001
Social competency
Low self-esteem 3717 (22.7) 21.8 to 23.7 1420 (16.9) 15.7 to 18.3 2297 (29.0) 27.5 to 30.5 <0.001
Low self-control 6166 (37.7) 36.6 to 38.9 3387 (39.5) 38.0 to 41.3 2779 (35.7) 34.1 to 37.5 0.001
Low self-efficacy 4238 (25.5) 24.5 to 26.6 1821 (21.6) 20.3 to 22.9 2417 (29.9) 28.4 to 31.5 <0.001
Family domain
Low parental supervision 6176 (37.7) 36.5 to 38.9 3567 (42.1) 40.4 to 43.7 2609 (32.8) 31.4 to 34.4 <0.001
Low social support 777 (4.6) 4.1 to 5.2 378 (4.4) 3.8 to 5.1 399 (4.8) 4.1 to 5.6 0.39
Low participation in family 
life
2948 (18.4) 17.5 to 19.5 1383 (16.8) 15.6 to 18.1 1565 (20.2) 18.9 to 21.7 <0.001
Peer domain
Low social support and 
affection from friends 
620 (3.5) 3.1 to 4.0 434 (4.8) 4.1 to 5.4 186 (2.1) 1.7 to 2.6 <0.001
Low prosocial behaviours 613 (3.6) 3.1 to 4.0 447 (5.0) 4.3 to 5.8 166 (2.0) 1.6 to 2.4 <0.001
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to assess NMUPM has been previously raised.28 This calls 
for more efforts to improve validity and reliability of 
NMUPM assessment tools. Second, the potential impact 
of desirability bias is always a concern in studies that are 
based on self-reported data. However, this bias is less 
likely, as the subsample already reported having used illicit 
drugs. Finally, the study was cross-sectional, which makes 
it impossible to examine temporal links between variables 
and to determine whether causal relations are plausible.
Conclusion
Our study allowed us to estimate the prevalence of NMUPM 
among adolescents who reported using drugs and to 
identify some associated factors. Our research emphasizes 
that it is important for clinicians to identify substance use 
for recreational or self-medicating purposes, including 
NMUPM in adolescents with mental health problems, 
especially regular or abusive use that can exacerbate or even 
hasten the onset of mental health problems. In addition, the 
risks of polysubstance use should be assessed for young 
people who take medications for nonmedical purposes, 
especially when they mix several substances, as this can 
have serious immediate health consequences. Schools might 
have a role in the prevention of NMUPM. In their review 
Table 3  Final multivariate analyses of correlates of 
nonmedical use of prescription medication
Multivariate analyses
Characteristics OR (95% CI)
Sex
Female 1.0 (Reference)
Male 1.16 (0.91 to 1.48)
Lifetime regular alcohol use 1.72 (1.36 to 2.16)
Number of illicit drugs used (≥2) 4.09 (3.06 to 5.48)
Attention-deficit disorder with or without 
hyperactivity 
1.47 (1.13 to 1.91)
Anxiety disorder 2.14 (1.57 to 2.92)
Low self-esteem 1.62 (1.26 to 2.08)
Low self-control 1.95 (1.55 to 2.45)
Low parental supervision 1.43 (1.11 to 1.83)
Table 2  Domain-specific analyses of correlates of nonmedical use of 
prescription medication
Bivariate analyses Multivariate analysesa
Characteristics OR (95% CI) OR (95% CI)
Sex, male 1.03 (0.83 to 1.28) n/a
Substance use
Lifetime regular alcohol use 2.50 (2.02 to 3.09) 1.88 (1.50 to 2.35)
Number of illicit drugs used (≥2) 6.01 (4.54 to 7.95) 5.30 (3.97 to 7.08)
Mental health
Attention-deficit disorder with or 
without hyperactivity 
 2.34 (1.86 to 2.94) 1.74 (1.36 to 2.22)
Anxiety disorder 3.13 (2.38 to 4.10) 2.00 (1.46 to 2.74)
Depression 3.57 (2.69 to 4.73) 2.31 (1.69 to 3.16)
Social competency
Low self-esteem 2.39 (1.92 to 2.99)  1.91 (1.51 to 2.41)
Low self-control 2.98 (2.37 to 3.74) 2.69 (2.12 to 3.40)
Low self-efficacy 1.76 (1.43 to 2.17)  1.14 (0.90 to 1.43)
Family domain
Low parental supervision 2.30 (1.82 to 2.89) 2.01 (1.59 to 2.55)
Low social support 2.39 (1.62 to 3.53) 1.46 (0.96 to 2.20)
Low participation in family life 2.17 (1.77 to 2.67) 1.67 (1.34 to 2.08)
Peer domain
Low social support and affection 
from friends 
2.29 (1.46 to 3.60) 1.95 (1.21 to 3.16)
Low prosocial behaviours 2.92 (2.04 to 4.20) 2.64 (1.80 to 3.87)
a Controlling for variables within each domain
n/a = not applicable
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of the literature, Griffin and Botvin48 and Hodder et al49 
highlighted the use of school-based prevention programs 
focused on skills (that is, social skills or self-regulation) and 
resilience training in adolescents as effective prevention 
strategies for drug use. Parents should also be made aware 
of the issue to ensure that medications are stored safely at 
home.
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